@RNAiAnalyst
aka Dirk Haussecker. Biotech enthusiast with expertise in sequence-directed therapeutics (RNAi, ASO, ADAR, CRISPR...) enjoying drug development and trying to make a buck along the way.
@proqr.bsky.social
Developing medicines using our proprietary Axiomer RNA-editing technology platform $PRQR #RNA #Biotech #Axiomer #RNAediting
@carolynbertozzi.bskyverified.social
Baker Family Director, Sarafan ChEM-H, Stanford University and HHMI; EIC of ACS Cent Sci; All views and opinions expressed are my own.
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@nature.com
Research, news, and commentary from Nature, the international science journal. For daily science news, get Nature Briefing: https://go.nature.com/get-Nature-Briefing
@findacureforhd.bsky.social
@vdion.bsky.social
Prof of DNA repair and neurodegeneration at the UK DRI at Cardiff university. Huntington’s disease Myotonic dystrophy and others
@hdfcures.bsky.social
The mission of the Hereditary Disease Foundation is to fund transformative research to find treatments, and ultimately a cure, for Huntington's disease and other related disorders. Learn more about us: HDFoundation.org
@hdai-ie.bsky.social
HDAI RCN 20025656. Sharing news on Huntingtons Disease /connecting to the international HD community. http://huntingtons.ie
@ehdn-news.bsky.social
European Huntington's Disease Network newsletter. Editor: Catherine Deeprose. Views are my own and RTs are not endorsements. Email: newsletter@ehdn.org
@rachiscahill.bsky.social
Neuroscientist working at the UCL HD Centre. Interested in Huntington’s disease, MRI, dogs, politics
@jcarroll42.bsky.social
Neuroscientist; Assoc.Prof. at University of Washington; Huntington’s Disease researcher; Army veteran. https://sites.uw.edu/jeffcarr/
@profwild.bsky.social
Queen Square Neurologist, Huntington’s disease researcher, Associate Director UCL HD Centre, co-founder HDBuzz
@ucl-hd.bsky.social
Committed to training the next generation of scientists and clinicians to contribute to the fight against Huntington's disease 🧬 @uclqsion.bsky.social
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@lifescivc.bsky.social
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
@erictopol.bsky.social
physician-scientist, author, editor https://www.scripps.edu/faculty/topol/ Ground Truths https://erictopol.substack.com SUPER AGERS https://www.simonandschuster.com/books/Super-Agers/Eric-Topol/9781668067666
@mortenlindow.bsky.social
Co-led scientific organisations, wholeness, evolution of purpose, oligonucleotide therapeutics, embedding of data science
@cureduchenne.bsky.social
Our mission is to cure Duchenne muscular dystrophy with our innovative venture philanthropy model that funds groundbreaking research, early diagnosis and treatment access.
@natesadeghi.bsky.social
Professional HC investor. May / may not have a position in stocks I tweet about. Dad. Mobâd. @columbia and C150 alumnus. Former @forbes & @thestreet writer.
@downtownjoshbrown.bsky.social
Investor, CEO, Dad https://www.downtownjoshbrown.com/
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@jacobplieth.bsky.social
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
@predatordiaries.com
Healthcare analyst after Principal in pricing & market access, healthcare fund manager, Scrip columnist & pharm PhD, MBA yada, yada. The other half of the http://smithandsheridan.eu podcast when we did it.
@natbiotech.nature.com
Publishing the best of biotech science and business. Part of @natureportfolio.bsky.social. Find us on Twitter, Facebook & Instagram.
@natureportfolio.nature.com
Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.